Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

73 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes

NCT00072475

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Ella Milbank Foshay Cancer Center at Jupiter Medical Center Jupiter, Florida, United States
View all 68 locations
View Trial Details
Completed

Topotecan in Treating Patients With Myelodysplastic Syndrome

NCT00003675

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

NCT00016419

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +7 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 94 locations
View Trial Details
Completed

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies

NCT00343798

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +145 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Denver, Colorado, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details

Related conditions